Search for: "Pfizer Inc." Results 201 - 220 of 1,378
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Judge Tosses Fraud Suit Against Seattle Genetics for Lack of Scienter
21 Jan 2018, 12:00 am by Rachel Neumann
Seattle Genetics, Inc., No. [read post]
The Race to the Bottom - https://www.theracetothebottom.org/blog/
La mort de la doctrine de la promesse!
17 Jan 2018, 9:04 am by Brian Daley
Pfizer Canada Inc. c. [read post]
Les Actifs creatifs - http://www.actifscreatifs.com/
The CAFC in Exmark v. Briggs & Stratton: "While this argument seems facially logical, it fails nonetheless."
14 Jan 2018, 1:37 pm by Lawrence B. Ebert
”Pfizer, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pfizer Inc. Announces It Will End Research on Alzheimer's & Parkinson Drugs
7 Jan 2018, 2:48 pm by Katherine C. Pearson, Dickinson Law, Penn State
According to the Wall Street Journal, Pfizer Inc released a public statement on Saturday, January 6, 2018, announcing the end of R & D for new drugs for treatment of Alzheimer's Disease and Parkinson's Disease. [read post]
Elder Law Prof Blog - http://lawprofessors.typepad.com/elder_law/
A Mass Action Must Involve Monetary Claims Brought By 100 Or More Persons Who ‘Propose To Try Those Claims Jointly’ As Named Plaintiffs
8 Dec 2017, 3:00 am by cafalawblog@mcglinchey.com (McGlinchey Stafford PLLC)
The plaintiffs in related cases originally filed their complaints in California state court alleging Lipitor, a prescription drug developed and manufactured by the defendant Pfizer, Inc. [read post]
Class Action Fairness Act Blog - http://www.cafalawblog.com/
Board Composition: More Insiders Needed?
17 Nov 2017, 3:00 am by John Jenkins
It fought the reelection of directors at companies such as Charter Communications Inc., Pfizer Inc. and PayPal Holdings, Inc., according to filings and a spokesman for the money manager. [read post]
TheCorporateCounsel.net Blog - http://www.thecorporatecounsel.net/Blog/
Guest Post: Second Circuit: Price Impact Evidence Not Always Necessary to Establish Market Efficiency
12 Nov 2017, 11:00 pm by Kevin LaCroix
A recurring issue in securities cases involves the question of when plaintiffs may rely on the presumption of reliance under the fraud on the market doctrine. [read post]
The D & O Diary - http://www.dandodiary.com/
Mere Suggestions Or Predictions To Join Coordinated Proceeding Are Insufficient To Trigger CAFA’s Mass Action Jurisdiction
10 Nov 2017, 3:00 am by cafalawblog@mcglinchey.com (McGlinchey Stafford PLLC)
Pfizer, Inc., No. 1:14-cv-00365 (E.D. [read post]
Class Action Fairness Act Blog - http://www.cafalawblog.com/
Retromark Volume II: the last six months in trade marks
11 Oct 2017, 8:17 am
RetroKatsDarren Meale (Simmons & Simmons and IPEC DDJ) returns with the second volume of his round up of trade mark litigation. [read post]
IPKat - http://ipkitten.blogspot.com/
The Director Compensation Project: Wells Fargo & Company (WFC)
10 Oct 2017, 12:00 am by Daniel Hamilton
Sanger serves as a director for Pfizer Inc., Mr. [read post]
The Race to the Bottom - https://www.theracetothebottom.org/blog/
D. Delaware addresses Heartland venue issue in case involving BMS' Eliquis®
11 Sep 2017, 5:35 pm by Lawrence B. Ebert
").CaseBRISTOL~MYERS SQUIBB COMPANY and PFIZER INC v, Mylan ["MPI"], 2017 U.S. [read post]
IPBiz - http://ipbiz.blogspot.com/
Big Pharma Faces More Pay-for-Delay Fallout
27 Aug 2017, 10:01 pm by Barry Barnett
Actavis, Inc. [read post]
The Contingency - http://www.thecontingency.com
Big Pharma Faces More Pay-for-Delay Fallout
27 Aug 2017, 10:01 pm by Barry Barnett
Actavis, Inc. [read post]
The Contingency - http://www.thecontingency.com
Judges Newman and Lourie express differences on obviousness in Stepan case
25 Aug 2017, 6:54 pm by Lawrence B. Ebert
” Pfizer, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
WOE — Zoloft Escapes a MDL While Third Circuit Creates a Conceptual Muddle
31 Jul 2017, 7:00 am by Schachtman
See generally Opposition Brief of Defendants-Appellees Pfizer Inc., Pfizer International LLC, and Greenstone LLC [cited as Pfizer]. [read post]
Tortini - http://schachtmanlaw.com/blog/
Chief Judge Stark Denies Plaintiffs’ Motion to Remand Removed Eliquis®Cases
3 Jul 2017, 10:10 am by Gregory B. Williams
Bristol-Myers Squibb Co. and Pfizer Inc. and 32 similar actions, Civil Action Nos. 17-609-LPS through 17-641-LPS, (D.Del. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Three Short-Supply Injectable Products Recalled Over Sterility Concerns
26 Jun 2017, 11:27 am by Jay W. Belle Isle
Over concerns of sterility, Hospira Inc., a Pfizer company, has voluntarily recalled three injectable products, as of June 15, 2017. [read post]
The Legal Reader - http://legalreader.com/
In IN RE: AFFINITY LABS OF TEXAS, LLC, case, CAFC emphasizes that estoppel provisions of pre-AIA section 317(b) are CLAIM-CENTRIC and PARTY-CENTRIC
5 May 2017, 11:24 am by Lawrence B. Ebert
See Apple Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Never Too Late: If you missed the IPKat last week!
30 Apr 2017, 4:30 am
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
IPKat - http://ipkitten.blogspot.com/
International Conflict Resolution Trip to Israel: Perspectives from a Property Law Professor
10 Apr 2017, 10:15 am by Vada W. Lindsey
City of New London, applied a deferential approach to the meaning of public use and permitted private property to be taken in favor of Pfizer, Inc. to revitalize the economically distressed city of New London. [read post]
Faculty Blog - http://law.marquette.edu/facultyblog/